FDA Approves Anti-Aging Drug Trial

Image Credit: Jim Linwood - Creative Commons

[ABSTRACT]

Last week, the FDA approved a clinical trial to determine if metformin, a well-known medication to control diabetes, might be used to prolong health in seniors. The study, known as TAME, Targeting Aging with Metformin, will start in 2016, pending receipt of sufficient funding. It will enroll 3,000 people between the ages of 70 and 80 who have cancer, cardio-vascular problems, or dementia, or are at risk for one of these health problems. The purpose of the study is to determine if metformin can extend healthy living in seniors by delaying the onset of age related diseases.

METFORMIN AS A DRUG FOR DIABETICS
Metformin has been used for decades to help control diabetes. It works by decreasing the amount of glucose absorbed from food and by reducing the amount of glucose produced by the liver. It is well tolerated by most people. It is also very inexpensive.

To see the full story, visit: http://whiteoakcottages.com/fda-approves-anti-aging-drug-trial/